PROMIS NEUROSCIENCES INC COMMON SHARES (OTCMKTS:ARFXF) Sellers Strengthened By 112.92% Their Shorts

May 16, 2018 - By Joseph Norton

ProMIS Neurosciences, Inc. (OTCMKTS:ARFXF) Corporate Logo

Change of 112.92% for PROMIS NEUROSCIENCES INC COMMON SHARES (OTCMKTS:ARFXF)’s shares shorted was showed. In May was published ARFXF’s total 37,900 shares shorted by FINRA. The 17,800 previous shares are up with 112.92%. PROMIS NEUROSCIENCES INC COMMON SHARES (OTCMKTS:ARFXF) has 205,600 shares average volume. It’ll cost 0 days for ARFXF to recover its previous position. 0.02% is PROMIS NEUROSCIENCES INC COMMON SHARES float short.

ARFXF is reaching $0.31 during the last trading session, after 0.32%.It’s since May 16, 2017 and is 0.00% down. ARFXF underperformed by 11.55% the S&P500.

ProMIS Neurosciences Inc., a development stage biotech company, discovers and develops precision medicine therapeutics for treatment of neurodegenerative diseases, primarily Alzheimer's disease and amyotrophic lateral sclerosis (ALS).The firm is valued at $74.11 million. The Company’s proprietary target discovery engine is based on the use of two complementary techniques.Currently it has negative earnings. The firm applies its thermodynamic, computational discovery platform?ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: